The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Murphy Keith since 2013.
The trader's CIK number is 1536583.
At the time of the last reporting, Murphy Keith was the Officer of Kintara Therapeutics, Inc.. (stock ticker symbol KTRA).
Also see all insider trading activities at Kintara Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | ONVO | 335,500 | $501,306 | 50,000 | $179,688 | 30,000 | $30,000 |
2016 | ONVO | 0 | $0 | 50,000 | $185,950 | 0 | $0 |
2015 | ONVO | 20,000 | $51,180 | 0 | $0 | 0 | $0 |
2014 | ONVO | 0 | $0 | 200,000 | $2,068,399 | 0 | $0 |
2013 | ONVO | 0 | $0 | 300,000 | $2,573,349 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | KTRA | 181,010 | $0 | 0 | $0 | 0 | $0 |
1. Organovo Holdings, Inc. (ONVO)
2. Kintara Therapeutics, Inc. (KTRA)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-11-22 | ONVO | Buy | 135,000 | 1.50 | 201,960 |
2017-11-24 | ONVO | Buy | 200,500 | 1.49 | 299,346 |
2017-02-09 | ONVO | Sale | 25,000 | 3.68 | 92,025 |
2017-02-08 | ONVO | Option Ex | 30,000 | 1.00 | 30,000 |
2017-01-24 | ONVO | Sale | 20,100 | 3.50 | 70,450 |
2017-01-23 | ONVO | Sale | 4,900 | 3.51 | 17,213 |
2016-12-14 | ONVO | Sale | 50,000 | 3.72 | 185,950 |
2015-08-12 | ONVO | Buy | 20,000 | 2.56 | 51,180 |
2014-02-18 | ONVO | Sale | 100,000 | 9.82 | 982,199 |
2014-01-21 | ONVO | Sale | 100,000 | 10.86 | 1,086,200 |
2013-12-10 | ONVO | Sale | 100,000 | 10.07 | 1,007,499 |
2013-11-13 | ONVO | Sale | 100,000 | 9.64 | 963,800 |
2013-10-16 | ONVO | Sale | 70,000 | 5.76 | 403,060 |
2013-10-18 | ONVO | Sale | 30,000 | 6.63 | 198,990 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-08-19 | KTRA | Buy | 181,010 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Murphy Keith (Officer of Kintara Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.